Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  Row 11: This percentage is calculated based on 13,971,990 outstanding shares of common stock of CalciMedica, Inc. (the "Issuer" or the "Company") as of May 6, 2025, as reported in the Company's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission ("SEC") on May 14, 2025 (the "Quarterly Report").


SCHEDULE 13G




Comment for Type of Reporting Person:  Rows 5, 7: Includes 1,583,153 shares of common stock held by Alafi Capital Company, LLC, for which Mr. Alafi is the managing member and for which he may be deemed to have sole voting or investment power. Row 11: This percentage is calculated based on 13,971,990 outstanding shares of common stock of the Company as reported in the Company's Quarterly Report.


SCHEDULE 13G



 
Alafi Capital Company, LLC
 
Signature:/s/ Christopher D. Alafi
Name/Title:Christopher D. Alafi, as managing member of Alafi Capital Company, LLC
Date:08/05/2025
 
Christopher D. Alafi
 
Signature:/s/ Christopher D. Alafi
Name/Title:Christopher D. Alafi
Date:08/05/2025
Exhibit Information

Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G (Previously Filed)